Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000230272 | SCV000287424 | likely benign | Hypertrophic cardiomyopathy 14 | 2022-12-21 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170251 | SCV001332811 | likely benign | Cardiomyopathy | 2018-02-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001555889 | SCV001777377 | likely benign | not provided | 2020-11-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002327127 | SCV002627340 | likely benign | Cardiovascular phenotype | 2019-09-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002487065 | SCV002801966 | likely benign | Hypertrophic cardiomyopathy 1; Dilated cardiomyopathy 1EE; Hypertrophic cardiomyopathy 14; Atrial septal defect 3; Sick sinus syndrome 3, susceptibility to | 2021-08-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002509329 | SCV002819289 | benign | not specified | 2022-12-06 | criteria provided, single submitter | clinical testing |